JPMORGAN CHASE & CO - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of EXELIXIS INC
ValueSharesWeighting
Q3 2023$167,113,647
+13.6%
7,648,221
-0.6%
0.02%
+12.5%
Q2 2023$147,064,233
-2.4%
7,695,668
-0.9%
0.02%
-11.1%
Q1 2023$150,709,000
+74947.2%
7,764,447
-38.0%
0.02%
-30.8%
Q4 2022$200,819
-99.9%
12,519,954
+1.4%
0.03%
-7.1%
Q3 2022$193,642,000
-23.4%
12,349,629
+1.7%
0.03%
-20.0%
Q2 2022$252,940,000
-7.4%
12,148,903
+0.8%
0.04%
+6.1%
Q1 2022$273,097,000
+25.1%
12,046,603
+0.9%
0.03%
+32.0%
Q4 2021$218,326,000
-9.6%
11,943,411
+4.5%
0.02%
-16.7%
Q3 2021$241,611,000
-6.2%
11,429,075
-19.1%
0.03%
-3.2%
Q2 2021$257,507,000
+0.3%
14,133,144
+24.4%
0.03%
-8.8%
Q1 2021$256,672,000
+9.7%
11,362,216
-2.6%
0.03%0.0%
Q4 2020$234,061,000
-2.2%
11,662,211
+19.4%
0.03%
-15.0%
Q3 2020$239,295,000
+3.9%
9,767,212
+0.7%
0.04%
-9.1%
Q2 2020$230,342,000
+57.1%
9,702,754
+14.0%
0.04%
+29.4%
Q1 2020$146,612,000
+7.5%
8,513,985
+10.0%
0.03%
+36.0%
Q4 2019$136,324,000
-5.3%
7,736,845
-5.0%
0.02%
-13.8%
Q3 2019$143,961,000
-15.6%
8,140,244
+2.4%
0.03%
-12.1%
Q2 2019$170,538,000
-27.9%
7,950,489
-20.0%
0.03%
-31.2%
Q1 2019$236,548,000
+33.2%
9,938,985
+10.1%
0.05%
+17.1%
Q4 2018$177,597,000
+69.0%
9,028,838
+52.2%
0.04%
+105.0%
Q3 2018$105,101,000
-10.4%
5,931,216
+8.8%
0.02%
-16.7%
Q2 2018$117,288,000
+5.2%
5,450,230
+8.2%
0.02%0.0%
Q1 2018$111,537,000
+36.2%
5,035,494
+86.9%
0.02%
+41.2%
Q4 2017$81,911,000
+123.9%
2,694,503
+78.4%
0.02%
+112.5%
Q3 2017$36,591,000
+482.9%
1,510,168
+492.6%
0.01%
+700.0%
Q2 2017$6,277,000
-33.7%
254,833
-41.7%
0.00%
-50.0%
Q1 2017$9,465,000
-36.1%
436,766
-56.0%
0.00%
-50.0%
Q4 2016$14,811,000
+110.1%
993,357
+80.2%
0.00%
+100.0%
Q3 2016$7,049,000
+430.4%
551,219
+224.1%
0.00%
Q2 2016$1,329,000
+33125.0%
170,073
+17916.2%
0.00%
Q1 2016$4,000
-99.9%
944
-99.8%
0.00%
-100.0%
Q3 2015$3,117,000
-29.6%
555,600
-55.6%
0.00%0.0%
Q1 2014$4,426,000
+837.7%
1,250,387
+1439.4%
0.00%
Q3 2013$472,000
-17.9%
81,228
-35.9%
0.00%
Q2 2013$575,000126,6280.00%
Other shareholders
EXELIXIS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 15,001,073$265,294,00064.62%
Sargent Investment Group, LLC 465,620$8,234,0003.70%
Orbimed Advisors 3,912,900$69,200,0001.31%
Bellevue Group AG 3,858,700$68,241,0001.27%
TEALWOOD ASSET MANAGEMENT INC 137,129$2,425,0001.04%
CAPITAL MANAGEMENT CORP /VA 200,995$3,555,0000.97%
Penn Capital Management Company, LLC 517,988$9,161,0000.96%
Chicago Capital, LLC 801,560$14,176,0000.95%
Portolan Capital Management 454,444$8,037,0000.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 103,534$1,830,0000.85%
View complete list of EXELIXIS INC shareholders